TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations.
View Top Employees from TC BioPharmWebsite | http://www.tcbiopharm.com |
Revenue | $15 million |
Funding | $13.4 million |
Employees | 75 (75 on RocketReach) |
Founded | 2014 |
Phone | +44 141 433 7557 |
Technologies |
JavaScript,
HTML,
Twitter
+26 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Clinical Grade Cell Therapy, Business Services, Science and Engineering, Cancer Immonotherapy, Health Care, Regenerative Medicine, Therapeutics, Stratified Medicine |
Web Rank | 8 Million |
Keywords | Tc Biopharm Jobs, Tc Biophram, Tc Biopharm |
Competitors | Eureka Therapeutics, Inc, Harpoon Therapeutics, InGeneron, SQZ Biotechnologies, Tessa Therapeutics Ltd |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular TC BioPharm employee's phone or email?
The TC BioPharm annual revenue was $15 million in 2024.
Angela Scott is the Chief Operating Officer and Founder of TC BioPharm.
75 people are employed at TC BioPharm.
The NAICS codes for TC BioPharm are [54171, 54, 541714, 541, 5417].
The SIC codes for TC BioPharm are [87, 873].